# OnCo record paper-nct04956640-nat-commun-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct04956640-nat-commun-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct04956640-nat-commun-2026" ;
  schema:name "Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study"@en ;
  schema:description "Published report from the trial registered as NCT04956640, in Nature Communications (2026), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct04956640-nat-commun-2026/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41467-026-69943-7>, <https://pubmed.ncbi.nlm.nih.gov/41820335/>, <https://europepmc.org/article/MED/41820335>, <https://clinicaltrials.gov/study/NCT04956640> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/s41467-026-69943-7> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Murciano-Goroff YR, Hollebecque A, Heist RS, et al." ;
  onco:trials <https://onco.cc/trials/nct04956640/> ;
  onco:journals <https://onco.cc/journals/nature-communications/> .